Ginkgo biloba and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Ginkgo biloba and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ginkgo
Brand name: Ginkgo biloba, Gingko Biloba
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ginkgo biloba-Insulin degludec
- Ginkgo biloba-Insulin Degludec (U-100) Prefilled Pens
- Ginkgo biloba-Insulin Degludec (U-100) Vials
- Ginkgo biloba-Insulin Degludec (U-200) Prefilled Pens
- Ginkgo biloba-Insulin degludec and liraglutide
- Ginkgo biloba-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Ginseng
- Insulin aspart, recombinant Subcutaneous-Glasdegib
- Insulin aspart, recombinant Subcutaneous-Glasdegib Maleate
- Insulin aspart, recombinant Subcutaneous-Glatiramer Acetate
- Insulin aspart, recombinant Subcutaneous-Glatiramer injection
- Insulin aspart, recombinant Subcutaneous-Glatiramer Subcutaneous